MAPT and Alzheimer disease: These observations fit well with previous research causally linking neurotoxic tau aggregates to synaptic dysfunction and loss in AD models (Lasagna-Reeves, 2011) and primary tauopathies (Bigio et al., 2001, Briel et al., 2022).